Clinical Trial Update: Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a low-dose treosulfan-based conditioning regimen for hematopoietic stem cell transplantation in Nijmegen Breakage Syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nijmegen Breakage Syndrome

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Nijmegen Breakage Syndrome | Phase 2 | Status: UNKNOWN